José Carreras International Leukemia Foundation

José Carreras International Leukemia Foundation
Name	José Carreras International Leukemia Foundation
Native name	Fundació Internacional Josep Carreras contra la Leucèmia
Founded	1988
Founder	José Carreras
Headquarters	Barcelona, Spain
Area served	International
Focus	Leukemia research, patient support, advocacy

José Carreras International Leukemia Foundation The José Carreras International Leukemia Foundation was established in 1988 by tenor José Carreras after his recovery from leukemia, creating a specialized institution focused on hematologic malignancies. The foundation operates from Barcelona with programs spanning research, patient support, clinical trials, and global partnerships involving hospitals, universities, and philanthropic organizations.

History

The foundation traces its origins to the public recovery of José Carreras and his subsequent announcement in 1987, which catalyzed support from figures such as Plácido Domingo, Luciano Pavarotti, and institutions like the World Health Organization, leading to formal establishment in 1988. Early collaborations involved Spanish entities including Hospital Clínic de Barcelona, Barcelona, and research groups linked to Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer. Through the 1990s the foundation expanded by partnering with European centers such as Institut Gustave Roussy, Karolinska Institutet, and the National Cancer Institute (United States), while engaging donors like Prince of Asturias and foundations connected to UNESCO and the European Commission. In the 2000s and 2010s the foundation responded to advances from teams led by researchers at Dana–Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, and Fred Hutchinson Cancer Research Center, integrating stem cell transplant programs inspired by progress from E. Donnall Thomas and Joseph E. Murray-era transplantation science. Recent decades saw expansion into Latin America and Africa with links to Instituto Nacional de Cancerología (Colombia), Fundación Favaloro, and health ministries of Argentina and South Africa.

Mission and Activities

The foundation's mission emphasizes support for research into acute lymphoblastic leukemia, acute myeloid leukemia, and other hematological malignancies, while promoting access to hematopoietic stem cell transplantation through networks including Bone Marrow Donors Worldwide and registries like Spanish Bone Marrow Donor Registry (REDMO). Activities include funding basic science at centers such as Max Planck Society, translational programs at institutions like Johns Hopkins University, and clinical trial support informed by protocols originating at National Institutes of Health (NIH). Public awareness campaigns have been coordinated with cultural partners including Teatro Real, media outlets like El País, and broadcasters such as Televisión Española to increase donor registration and early diagnosis.

Research and Funding Initiatives

Research initiatives have funded investigations into molecular drivers identified by groups at Cold Spring Harbor Laboratory, The Sanger Institute, and Harvard Medical School, targeting mutations described in landmark work from James D. Watson-era genetics and sequencing consortia including 1000 Genomes Project. Grants and fellowships support principal investigators in laboratories affiliated with University College London, Heidelberg University, and Università di Milano, covering projects in immunotherapy, chimeric antigen receptor T cell research pioneered at University of Pennsylvania, and targeted therapies influenced by discoveries from Christiane Nüsslein-Volhard-associated developmental biology frameworks. The foundation administers scholarships and seed funding comparable to programs at Wellcome Trust and Marie Curie Actions, and co-funds multicenter trials with cooperative groups such as European Society for Blood and Marrow Transplantation and Grupo Español de Trasplante Hematopoyético.

Patient Support and Advocacy

Patient support programs mirror services developed at comprehensive cancer centers like MD Anderson Cancer Center and Royal Marsden Hospital, offering psychosocial counseling, transplant navigation, and survivorship resources modeled after interventions from American Cancer Society and Macmillan Cancer Support. Advocacy efforts have lobbied national health authorities in Spain, Germany, and France for improved transplant access and registry harmonization, engaging policymakers from European Parliament committees and regulatory agencies including the European Medicines Agency. The foundation collaborates with patient organizations such as Leukemia & Lymphoma Society and Blood Cancer UK to standardize care pathways and patient-reported outcome measures influenced by work at Stanford University.

Fundraising and Events

High-profile fundraising has included benefit concerts involving artists associated with The Three Tenors, gala dinners hosted at venues like Palau de la Música Catalana, and partnerships with corporate donors such as multinational firms comparable to Telefonica and luxury houses similar to Grupo Puig. Signature events include donor drives coordinated with national bone marrow registries and public awareness marathons inspired by models from Susan G. Komen Foundation and Comic Relief. Fundraising campaigns leverage partnerships with broadcasters such as BBC and streaming platforms linked to YouTube for global reach.

Governance and Organization

The foundation is governed by a board of trustees and scientific advisory boards composed of clinicians and researchers from institutions including Hospital Universitari Vall d'Hebron, Karolinska University Hospital, and Mount Sinai Health System. Administrative headquarters in Barcelona oversee regional offices that report to executive leadership, while audit processes reflect standards used by non-profits such as International Committee of the Red Cross financial oversight practices and grant compliance akin to those at Bill & Melinda Gates Foundation-funded programs. Ethical review for funded projects aligns with committees modeled on Declaration of Helsinki principles and institutional review boards from partner universities.

Partnerships and Collaborations

The foundation maintains collaborations with international centers and networks including European Hematology Association, World Marrow Donor Association, and national registries such as Registro Español de Donantes de Médula Ósea, while contributing to multinational consortia that include EORTC and translational platforms at CRUK-affiliate laboratories. Academic partnerships span University of Oxford, Yale School of Medicine, and University of Tokyo, and philanthropic alliances involve foundations resembling Rockefeller Foundation and Carnegie Corporation to scale research, registry expansion, and capacity building in low-resource settings such as programs with Partners In Health initiatives.

Category:Medical and health foundations